Chloroquine Tablets
Formulated to target malaria parasites to support resolution of infection.
Strengths: 250 · 500mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Avloclor; Nivaquine
- Therapeutic class
Antimalarial
- Pharmacological class
4-Aminoquinoline
- Known off-label uses
lupus erythematosus
- Contraindications
hypersensitivity to chloroquine; retinal changes; epilepsy
- Precautions and warnings
regular eye examinations required during long-term use; may impair vision
- Minor side effects
nausea; headache; dizziness
- Moderate side effects
skin rash; visual disturbances
- Dosage forms
Tablet
- Administration route
Oral use
- Patient summary
Formulated to target malaria parasites to support resolution of infection.
- Prescription status
POM
- Manufacturer
Sanofi
- Onset Time
1–2 hours
- Duration
Indeterminate
- Storage instructions
Store in a cool, dry place.
- Drug interactions
Antacids; Ciclosporin
- Age restrictions
Dosing should be adjusted according to weight.
- Pregnancy and breastfeeding
Pregnancy: consult your doctor. Breastfeeding: use only if essential.
Serious side effects
retinopathy — requires immediate medical attention; cardiomyopathy — requires immediate medical attention
Mechanism of action
Interferes with the parasite's ability to detoxify heme within its food vacuole, resulting in an accumulation of toxic heme and the subsequent death of the parasite in the host blood cells.
Chloroquine Tablets
Formulated to target malaria parasites to support resolution of infection.
Editorial Notes
- Active ingredient(s): Chloroquine
- Listed indication(s): Malaria, Rheumatoid Arthritis
Usually available as
- 180 tablets - 250 mg1128-250-mg-13357
- 180 tablets - 500 mg1128-500-mg-13363